Epitopea Limited is a private limited company registered at Salisbury House, Station Road, Cambridge CB1 2LA. Its net worth is valued to be around 0 pounds, while the fixed assets the company owns come to 0 pounds. Incorporated on 2021-04-23, this 3-year-old company is run by 5 directors.
Director Alan R., appointed on 22 December 2023. Director Satish J., appointed on 14 March 2023. Director Maxime P., appointed on 07 December 2021.
The company is categorised as "research and experimental development on biotechnology" (SIC: 72110).
The last confirmation statement was filed on 2023-04-22 and the due date for the subsequent filing is 2024-05-06. Additionally, the annual accounts were filed on 30 April 2022 and the next filing should be sent on 31 January 2024.
| Office Address | Salisbury House |
| Office Address2 | Station Road |
| Town | Cambridge |
| Post code | CB1 2LA |
| Country of origin | United Kingdom |
| Registration Number | 13354764 |
| Date of Incorporation | Fri, 23rd Apr 2021 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 30th April |
| Company age | 3 years old |
| Account next due date | Wed, 31st Jan 2024 (137 days after) |
| Account last made up date | Sat, 30th Apr 2022 |
| Next confirmation statement due date | Mon, 6th May 2024 (2024-05-06) |
| Last confirmation statement dated | Sat, 22nd Apr 2023 |
Position: Director
Appointed: 22 December 2023
Position: Director
Appointed: 14 March 2023
Position: Director
Appointed: 07 December 2021
Position: Director
Appointed: 30 November 2021
Position: Director
Appointed: 30 November 2021
The register of persons with significant control that own or have control over the company includes 2 names. As BizStats researched, there is Advent Life Sciences Llp from London, England. This PSC is categorised as "a limited liability partnership", has 25-50% voting rights and has 25-50% shares. This PSC has 25-50% voting rights and has 25-50% shares. Another entity in the persons with significant control register is Jonathan M. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.
Advent Life Sciences Llp
27 Fitzroy Square, London, W1T 6ES, England
| Legal authority | Limited Liability Partnerships Act 2000 |
| Legal form | Limited Liability Partnership |
| Country registered | England |
| Place registered | Companies House |
| Registration number | Oc347034 |
| Notified on | 30 November 2021 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Jonathan M.
| Notified on | 23 April 2021 |
| Ceased on | 30 November 2021 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights |
| Profit & Loss | ||
|---|---|---|
| Accounts Information Date | 2022-04-30 | 2023-04-30 |
| Balance Sheet | ||
| Current Assets | 1 155 343 | 1 288 779 |
| Net Assets Liabilities | -1 075 240 | -2 799 201 |
| Other | ||
| Accrued Liabilities | 17 028 | 26 101 |
| Accumulated Depreciation Impairment Property Plant Equipment | 470 | 7 496 |
| Additions Other Than Through Business Combinations Property Plant Equipment | 4 605 | 32 025 |
| Administrative Expenses | 1 220 326 | 2 100 921 |
| Applicable Tax Rate | 0 | 0 |
| Average Number Employees During Period | 2 | 7 |
| Balances Amounts Owed By Related Parties | 15 504 | |
| Balances Amounts Owed To Related Parties | 1 697 | |
| Cash Cash Equivalents | 810 831 | 753 020 |
| Cash Cash Equivalents Cash Flow Value | 810 831 | 753 020 |
| Comprehensive Income Expense | -2 151 828 | -3 555 416 |
| Corporation Tax Recoverable | 179 024 | 366 151 |
| Current Liabilities | 2 234 718 | 4 117 114 |
| Current Tax For Period | -179 024 | -366 151 |
| Depreciation Expense Property Plant Equipment | 470 | 7 026 |
| Further Item Increase Decrease In Equity Component Total Income Expense Recognised Directly In Equity | 53 596 | |
| Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | 47 873 | 48 242 |
| Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | -165 488 | -4 120 |
| Gain Loss In Cash Flows From Other Change In Operating Assets | 2 116 788 | 1 587 591 |
| Income Expense Recognised Directly In Equity | 674 | 53 747 |
| Income From Related Parties | 203 625 | |
| Income Taxes Paid Refund Classified As Operating Activities | 179 024 | |
| Income Tax Expense Credit | -179 024 | -366 151 |
| Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | 810 831 | -57 811 |
| Increase From Depreciation Charge For Year Property Plant Equipment | 470 | 7 026 |
| Interest Paid Classified As Operating Activities | 70 057 | 246 563 |
| Interest Payable Similar Charges Finance Costs | 70 057 | 246 563 |
| Issue Equity Instruments | 674 | 151 |
| Net Cash Flows From Used In Financing Activities | 674 | 151 |
| Net Cash Flows From Used In Investing Activities | -4 605 | -32 025 |
| Net Cash Flows From Used In Operating Activities | 814 762 | -25 937 |
| Net Cash Generated From Operations | 814 762 | -204 961 |
| Nominal Value Shares Issued In Period | 510 | 151 |
| Non-current Assets | 4 135 | 29 134 |
| Number Shares Issued Fully Paid | 5 101 000 | 6 609 250 |
| Number Shares Issued In Period- Gross | 5 101 000 | 1 508 250 |
| Operating Profit Loss | -1 184 881 | -1 897 296 |
| Other Payables | 3 067 | 7 637 |
| Other Receivables | 69 177 | 79 582 |
| Pension Costs Defined Contribution Plan | 7 894 | 48 206 |
| Prepayments Accrued Income | 60 866 | 74 522 |
| Proceeds From Issuing Shares | 674 | 151 |
| Profit Loss | -1 075 914 | -1 777 708 |
| Profit Loss Before Tax | -1 075 914 | -1 777 708 |
| Property Plant Equipment Gross Cost | 4 605 | 36 630 |
| Property Plant Equipment Including Right-of-use Assets | 4 135 | 29 134 |
| Purchase Property Plant Equipment | 4 605 | 32 025 |
| Redeemable Preference Shares Liability | 2 186 845 | 4 020 999 |
| Share-based Payment Expense Cash Settled | 53 596 | |
| Social Security Costs | 425 | 41 501 |
| Staff Costs Employee Benefits Expense | 90 270 | 700 184 |
| Taxation Social Security Payable | 4 242 | 15 465 |
| Tax Expense Credit Applicable Tax Rate | -238 438 | -407 333 |
| Tax Increase Decrease From Effect Dividends From U K Companies | -77 031 | -246 563 |
| Tax Increase Decrease From Effect Unrelieved Tax Losses Carried Forward | 49 649 | 462 807 |
| Tax Increase Decrease From Other Tax Effects Tax Reconciliation | 86 796 | -175 062 |
| Total Assets | 1 159 478 | 1 317 913 |
| Total Borrowings | -2 186 845 | -4 020 999 |
| Total Liabilities | 2 234 718 | 4 117 114 |
| Trade Creditors Trade Payables | 23 536 | 46 912 |
| Trade Debtors Trade Receivables | 35 445 | 15 504 |
| Trade Other Payables | 47 873 | 96 115 |
| Trade Other Receivables | 344 512 | 535 759 |
| Turnover Revenue | 35 445 | 203 625 |
| Wages Salaries | 81 951 | 610 477 |
| Company Contributions To Defined Benefit Plans Directors | 6 690 | 20 655 |
| Director Remuneration | 66 903 | 236 925 |
| Director Remuneration Benefits Including Payments To Third Parties | 73 593 | 305 080 |
| Number Directors Who Received Or Were Entitled To Receive Shares Under Long Term Incentive Schemes | 1 | |
| Payments To Third Parties For Director Services | 47 500 | |
| Type | Category | Free download | |
|---|---|---|---|
| CS01 |
Confirmation statement with updates 2024/04/22 filed on: 16th, May 2024 |
confirmation statement | Free Download (5 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy